Study shows how circulating tumor cells target distant organs

by University of Southern CaliforniaDevelopment of brain metastasis is a complex process in which metastatic cells (green) overcome the protective effect of immune cells (red). Credit: University

Updated on: May 31,2024

Study shows how circulating tumor cells target distant organs

by University of Southern CaliforniaDevelopment of brain metastasis is a complex process in which metastatic cells (green) overcome the protective effect of immune cells (red). Credit: University

Updated on:May 31,2024

Scholar aims to reverse-engineer cancer with 3D tool

by Kim Horner,University of Texas at DallasDr. Chen Cao (center), assistant professor of bioengineering, is shown with some members of her lab, from left, biomedical engineering junior Namyuktha

Updated on: September 28,2024

Scholar aims to reverse-engineer cancer with 3D tool

by Kim Horner,University of Texas at DallasDr. Chen Cao (center), assistant professor of bioengineering, is shown with some members of her lab, from left, biomedical engineering junior Namyuktha

Updated on:September 28,2024

Special RNA shown to suppress the formation of breast cancer cells

JANUARY 16, 2024by Sebastian Hollstein,Friedrich Schiller University of JenaCredit:Cell Reports(2024). DOI: 10.1016/j.celrep.2023.113644Breast cancer is the most common cancer in wom

Updated on: March 25,2024

Special RNA shown to suppress the formation of breast cancer cells

JANUARY 16, 2024by Sebastian Hollstein,Friedrich Schiller University of JenaCredit:Cell Reports(2024). DOI: 10.1016/j.celrep.2023.113644Breast cancer is the most common cancer in wom

Updated on:March 25,2024

Neoadjuvant immunotherapy with relatlimab and nivolumab is safe and effective in stage III melanoma

byUniversity of Texas M. D. Anderson Cancer CenterCredit: CC0 Public DomainGiving the combination of immune checkpoint inhibitors relatlimab and nivolumab to patients with stage III melanoma bef

Updated on: January 13,2024

Neoadjuvant immunotherapy with relatlimab and nivolumab is safe and effective in stage III melanoma

byUniversity of Texas M. D. Anderson Cancer CenterCredit: CC0 Public DomainGiving the combination of immune checkpoint inhibitors relatlimab and nivolumab to patients with stage III melanoma bef

Updated on:January 13,2024

Researchers develop an improved hereditary cancer test

by University of British ColumbiaCredit:Cell Genomics(2022). DOI: 10.1016/j.xgen.2022.100233Researchers at the BC Cancer Research Institute have made an advancement in genetic testing

Updated on: February 03,2024

Researchers develop an improved hereditary cancer test

by University of British ColumbiaCredit:Cell Genomics(2022). DOI: 10.1016/j.xgen.2022.100233Researchers at the BC Cancer Research Institute have made an advancement in genetic testing

Updated on:February 03,2024

Researchers investigate effects of pharmacological antioxidant compound DPDT on tumor cells

by Impact Journals LLCApoptosis induction by DPDT. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28465A new research paper has been published in the journalOncotargetentitled, &q

Updated on: February 18,2024

Researchers investigate effects of pharmacological antioxidant compound DPDT on tumor cells

by Impact Journals LLCApoptosis induction by DPDT. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28465A new research paper has been published in the journalOncotargetentitled, &q

Updated on:February 18,2024

Biosensors for bladder cancer diagnosis

by University of BathCredit: AI-generated imageCancer constitutes one of the leading causes of mortality worldwide. As early diagnosis is paramount to improved clinical outcome and survival, sens

Updated on: May 09,2024

Biosensors for bladder cancer diagnosis

by University of BathCredit: AI-generated imageCancer constitutes one of the leading causes of mortality worldwide. As early diagnosis is paramount to improved clinical outcome and survival, sens

Updated on:May 09,2024

Novobiocin attacks BRCA-mutated cancer cells from within and without, study shows

byDana-Farber Cancer InstituteEfficacy of POLθ inhibition in HR-deficient cancers requires CD8+T cells.a,bK14-Cre-Brca1f/f;Trp53f/fTNBC tumors from syngeneic FVB/12

Updated on: January 23,2024

Novobiocin attacks BRCA-mutated cancer cells from within and without, study shows

byDana-Farber Cancer InstituteEfficacy of POLθ inhibition in HR-deficient cancers requires CD8+T cells.a,bK14-Cre-Brca1f/f;Trp53f/fTNBC tumors from syngeneic FVB/12

Updated on:January 23,2024

AI facilitates breakthrough in sinonasal cancer diagnostics

byLudwig Maximilian University of MunichMethylation array for the determination of DNA modifications. Credit: Jurmeister et al.Although tumors in the nasal cavity and the paranasal sinus are con

Updated on: January 02,2024

AI facilitates breakthrough in sinonasal cancer diagnostics

byLudwig Maximilian University of MunichMethylation array for the determination of DNA modifications. Credit: Jurmeister et al.Although tumors in the nasal cavity and the paranasal sinus are con

Updated on:January 02,2024

Researchers use machine learning to unlock the genomic code in clinical cancer samples

by University of HelsinkiMutational signatures of formalin exposure. a C>T FFPE-only mutation count increases with formalin fixation time. We observed this increase in both unrepaired and repa

Updated on: February 18,2024

Researchers use machine learning to unlock the genomic code in clinical cancer samples

by University of HelsinkiMutational signatures of formalin exposure. a C>T FFPE-only mutation count increases with formalin fixation time. We observed this increase in both unrepaired and repa

Updated on:February 18,2024

Race could affect outcomes in head and neck cancers

by Cara Murez HealthDay ReporterBlack patients with head and neck cancers have twice the death rates of white patients, and a new study suggests race itself underlies those differences."What is u

Updated on: January 22,2024

Race could affect outcomes in head and neck cancers

by Cara Murez HealthDay ReporterBlack patients with head and neck cancers have twice the death rates of white patients, and a new study suggests race itself underlies those differences."What is u

Updated on:January 22,2024

Therapeutic and diagnostic functions of one antibody for pancreatic cancer

by Osaka UniversityFig.1: DKK1–CKAP4 signaling and application of the anti-CKAP4 antibody. DKK1 and CKAP4 are overexpressed in cancer cells and the PI3 kinase–AKT pathway is activated, promoting

Updated on: May 20,2024

Therapeutic and diagnostic functions of one antibody for pancreatic cancer

by Osaka UniversityFig.1: DKK1–CKAP4 signaling and application of the anti-CKAP4 antibody. DKK1 and CKAP4 are overexpressed in cancer cells and the PI3 kinase–AKT pathway is activated, promoting

Updated on:May 20,2024